These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 20539230)
1. Thrombotic microangiopathies: new insights and new challenges. Zipfel PF; Heinen S; Skerka C Curr Opin Nephrol Hypertens; 2010 Jul; 19(4):372-8. PubMed ID: 20539230 [TBL] [Abstract][Full Text] [Related]
2. Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles. Skerka C; Licht C; Mengel M; Uzonyi B; Strobel S; Zipfel PF; Józsi M Mol Immunol; 2009 Sep; 46(14):2801-7. PubMed ID: 19640589 [TBL] [Abstract][Full Text] [Related]
4. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS). Licht C; Stapenhorst L; Simon T; Budde U; Schneppenheim R; Hoppe B Kidney Int; 2004 Sep; 66(3):955-8. PubMed ID: 15327386 [TBL] [Abstract][Full Text] [Related]
5. Thrombotic microangiopathies: from animal models to human disease and cure. Caprioli J; Remuzzi G; Noris M Contrib Nephrol; 2011; 169():337-350. PubMed ID: 21252531 [TBL] [Abstract][Full Text] [Related]
6. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring. Mannucci PM; Cugno M Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489 [TBL] [Abstract][Full Text] [Related]
8. [Pathophysiology of thrombotic microangiopathies: current understanding]. Coppo P; Veyradier A; Durey MA; Fremeaux-Bacchi V; Scrobohaci ML; Amesland F; Bussel A Ann Med Interne (Paris); 2002 May; 153(3):153-66. PubMed ID: 12218898 [TBL] [Abstract][Full Text] [Related]
9. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease. Furlan M; Lämmle B Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108 [TBL] [Abstract][Full Text] [Related]
10. Thrombotic microangiopathy: new insights. Benz K; Amann K Curr Opin Nephrol Hypertens; 2010 May; 19(3):242-7. PubMed ID: 20186056 [TBL] [Abstract][Full Text] [Related]
11. Recent advances in thrombotic thrombocytopenic purpura. Sadler JE; Moake JL; Miyata T; George JN Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695 [TBL] [Abstract][Full Text] [Related]
12. Thrombotic microangiopathies: towards a pathophysiology-based classification. Coppo P; Veyradier A Cardiovasc Hematol Disord Drug Targets; 2009 Mar; 9(1):36-50. PubMed ID: 19275576 [TBL] [Abstract][Full Text] [Related]
14. Novel developments in thrombotic microangiopathies: is there a common link between hemolytic uremic syndrome and thrombotic thrombocytic purpura? Zipfel PF; Wolf G; John U; Kentouche K; Skerka C Pediatr Nephrol; 2011 Nov; 26(11):1947-56. PubMed ID: 21671028 [TBL] [Abstract][Full Text] [Related]
15. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other? Shibagaki Y; Fujita T Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259 [TBL] [Abstract][Full Text] [Related]
16. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Veyradier A; Obert B; Houllier A; Meyer D; Girma JP Blood; 2001 Sep; 98(6):1765-72. PubMed ID: 11535510 [TBL] [Abstract][Full Text] [Related]
18. [Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura]. Masset C; Dubois B; Rorive G Rev Med Liege; 2002 Jan; 57(1):33-9. PubMed ID: 11899496 [TBL] [Abstract][Full Text] [Related]
19. Syndromes of Thrombotic Microangiopathy. Shatzel JJ; Taylor JA Med Clin North Am; 2017 Mar; 101(2):395-415. PubMed ID: 28189178 [TBL] [Abstract][Full Text] [Related]